- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 58,365,166
- Total 13F shares
- 3,491,619
- Share change
- -165,658
- Total reported value
- $797,768,609
- Price per share
- $228.73
- Number of holders
- 88
- Value change
- -$32,248,877
- Number of buys
- 51
- Number of sells
- 42
Quarterly Holders Quick Answers
What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 04351P101:
Top shareholders of ASND - Ascendis Pharma A/S - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
18%
|
10,281,496
|
$2,192,426,207 | — | 31 Dec 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13D/G
13F
|
Westfield Capital Management Company, L.P. · Company |
8.5%
|
5,185,696
|
$1,115,183,925 | -$73,663,872 | 31 Dec 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.8%
|
5,111,111
|
$1,089,893,310 | — | 31 Dec 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
6.6%
|
3,852,101
|
$957,439,699 | -$197,557,979 | 31 Mar 2026 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
7.8%
from 13D/G
|
4,061,641
|
$866,104,326 | — | 31 Dec 2025 | |
| Artisan Partners Limited Partnership |
13D/G
13F
|
Artisan Partners Asset Management Inc. · Company |
5.2%
|
3,225,885
|
$687,887,717 | $0 | 31 Dec 2025 | |
| Capital International Investors |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
3,063,943
|
$653,355,205 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
4.8%
|
2,667,563
|
$530,338,200 | -$182,106,580 | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.3%
|
1,910,079
|
$407,305,320 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
3.2%
|
1,886,393
|
$402,254,443 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3%
|
1,762,721
|
$375,882,627 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.7%
|
1,570,260
|
$334,843,000 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.5%
|
1,443,141
|
$307,736,614 | — | 31 Dec 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.9%
|
1,081,421
|
$230,602,214 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.8%
|
1,026,407
|
$218,871,029 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
628,200
|
$133,957,368 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
617,968
|
$131,775,763 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
596,703
|
$127,240,947 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
586,094
|
$124,978,684 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.94%
|
550,477
|
$117,383,715 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.89%
|
519,516
|
$110,781,591 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.87%
|
507,240
|
$108,163,857 | — | 31 Dec 2025 | |
| Jan Moller Mikkelsen |
3/4/5
|
Director |
0.78%
|
453,403
|
$106,545,170 | — | 18 Mar 2026 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
0.85%
|
496,837
|
$105,946,000 | — | 31 Dec 2025 | |
| FIL Ltd |
13F
|
Company |
0.82%
|
478,641
|
$102,065,407 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.81%
|
470,951
|
$100,425,591 | — | 31 Dec 2025 | |
| Spyglass Capital Management LLC |
13F
|
Company |
0.71%
|
415,549
|
$88,611,669 | — | 31 Dec 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.63%
|
370,473
|
$78,999,663 | — | 31 Dec 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
352,109
|
$75,083,723 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.53%
|
308,190
|
$65,718,435 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.53%
|
307,086
|
$65,483,019 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.51%
|
296,818
|
$63,293,470 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.49%
|
288,592
|
$61,539,358 | — | 31 Dec 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.48%
|
281,473
|
$60,021,329 | — | 31 Dec 2025 | |
| Tri Locum Partners LP |
13F
|
Company |
0.45%
|
265,015
|
$56,511,799 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.45%
|
262,329
|
$55,939,036 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.42%
|
247,892
|
$52,860,490 | — | 31 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.4%
|
235,862
|
$50,295,213 | — | 31 Dec 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.4%
|
234,012
|
$49,900,719 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.38%
|
221,677
|
$47,270,404 | — | 31 Dec 2025 | |
| Jain Global LLC |
13F
|
Company |
0.37%
|
216,526
|
$46,172,004 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
216,173
|
$46,096,731 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.35%
|
203,500
|
$43,394,340 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
194,605
|
$41,497,458 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.33%
|
193,464
|
$41,254,263 | — | 31 Dec 2025 | |
| Q Global Advisors, LLC |
13F
|
Company |
0.33%
|
190,000
|
$40,516,000 | — | 31 Dec 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.32%
|
187,642
|
$40,022,162 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.32%
|
186,940
|
$39,864,783 | — | 31 Dec 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.31%
|
182,234
|
$38,859,578 | — | 31 Dec 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.3%
|
177,685
|
$37,889,549 | — | 31 Dec 2025 |
Institutional Holders of Ascendis Pharma A/S - COMMON STOCK (ASND) as of Q1 2026
As of 31 Mar 2026,
Ascendis Pharma A/S - COMMON STOCK (ASND) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,491,619 shares.
The largest 10 holders included
PRINCIPAL FINANCIAL GROUP INC, Pictet Asset Management Holding SA, Candriam S.C.A., Bank of New York Mellon Corp, Aberdeen Group plc, ARS Investment Partners, LLC, UBS Group AG, Allspring Global Investments Holdings, LLC, NEW YORK STATE COMMON RETIREMENT FUND, and DEUTSCHE BANK AG\.
This page lists
90
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
304
Q1 2026 holders
88
Holder diff
-216
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.